EC Number   |
Title |
Organism |
|---|
   3.4.21.35 | Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer |
Homo sapiens |
| 3.4.21.35 | Biosynthesis and secretion of human tissue kallikrein in transgenic Chlamydomonas reinhardtii |
Homo sapiens |
| 3.4.21.35 | Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage |
Homo sapiens |
| 3.4.21.35 | Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer |
Homo sapiens |
| 3.4.21.35 | The natural flavone fukugetin as a mixed-type inhibitor for human tissue kallikreins |
Homo sapiens |
| 3.4.21.35 | Tissue kallikrein (KLK1) regulates alveolar macrophage apoptosis early in influenza virus infection |
Mus musculus |
| 3.4.21.35 | Tissue kallikrein protects SH-SY5Y neuronal cells against oxygen and glucose deprivation-induced injury through bradykinin B2 receptor-dependent regulation of autophagy induction |
Homo sapiens |
| 3.4.21.35 | A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor |
Rattus norvegicus |
| 3.4.21.35 | A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein |
Homo sapiens |
| 3.4.21.35 | An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein |
Rattus norvegicus |
